BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 28744870)

  • 1. Fast dose optimization for rotating shield brachytherapy.
    Cho M; Wu X; Dadkhah H; Yi J; Flynn RT; Kim Y; Xu W
    Med Phys; 2017 Oct; 44(10):5384-5392. PubMed ID: 28744870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asymmetric dose-volume optimization with smoothness control for rotating-shield brachytherapy.
    Liu Y; Flynn RT; Kim Y; Wu X
    Med Phys; 2014 Nov; 41(11):111709. PubMed ID: 25370623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paddle-based rotating-shield brachytherapy.
    Liu Y; Flynn RT; Kim Y; Dadkhah H; Bhatia SK; Buatti JM; Xu W; Wu X
    Med Phys; 2015 Oct; 42(10):5992-6003. PubMed ID: 26429274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multihelix rotating shield brachytherapy for cervical cancer.
    Dadkhah H; Kim Y; Wu X; Flynn RT
    Med Phys; 2015 Nov; 42(11):6579-88. PubMed ID: 26520749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic rotating-shield brachytherapy.
    Liu Y; Flynn RT; Kim Y; Yang W; Wu X
    Med Phys; 2013 Dec; 40(12):121703. PubMed ID: 24320489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The population percentile allowance method for determining systematic spatial error tolerances for temporary intensity modulated brachytherapy.
    Hopfensperger KM; Adams QE; Kim Y; Wu X; Xu W; Patwardhan K; Flynn RT
    Med Phys; 2023 Oct; 50(10):6469-6478. PubMed ID: 37643427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rotating-shield brachytherapy for cervical cancer.
    Yang W; Kim Y; Wu X; Song Q; Liu Y; Bhatia SK; Sun W; Flynn RT
    Phys Med Biol; 2013 Jun; 58(11):3931-41. PubMed ID: 23680601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid emission angle selection for rotating-shield brachytherapy.
    Liu Y; Flynn RT; Yang W; Kim Y; Bhatia SK; Sun W; Wu X
    Med Phys; 2013 May; 40(5):051720. PubMed ID: 23635268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel two-step optimization method for tandem and ovoid high-dose-rate brachytherapy treatment for locally advanced cervical cancer.
    Sharma M; Fields EC; Todor DA
    Brachytherapy; 2015; 14(5):613-8. PubMed ID: 26092424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Needle-free cervical cancer treatment using helical multishield intracavitary rotating shield brachytherapy with the
    Hopfensperger KM; Adams Q; Kim Y; Wu X; Xu W; Patwardhan K; Thammavong B; Caster J; Flynn RT
    Med Phys; 2020 Jun; 47(5):2061-2071. PubMed ID: 32073669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel minimally invasive dynamic-shield, intensity-modulated brachytherapy system for the treatment of cervical cancer.
    Morcos M; Antaki M; Viswanathan AN; Enger SA
    Med Phys; 2021 Jan; 48(1):71-79. PubMed ID: 32916763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comprehensive evaluation of adaptive daily planning for cervical cancer HDR brachytherapy.
    Meerschaert R; Nalichowski A; Burmeister J; Paul A; Miller S; Hu Z; Zhuang L
    J Appl Clin Med Phys; 2016 Nov; 17(6):323-333. PubMed ID: 27929505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative evaluation of two dose optimization methods for image-guided, highly-conformal, tandem and ovoids cervix brachytherapy planning.
    Ren J; Menon G; Sloboda R
    Phys Med Biol; 2013 Apr; 58(7):2045-58. PubMed ID: 23459004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interstitial rotating shield brachytherapy for prostate cancer.
    Adams QE; Xu J; Breitbach EK; Li X; Enger SA; Rockey WR; Kim Y; Wu X; Flynn RT
    Med Phys; 2014 May; 41(5):051703. PubMed ID: 24784369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dose Distribution Optimization in Combined Intracavitary and Interstitial Brachytherapy for Cervical Cancer].
    Ozaki D; Miyazawa M; Habano Y; Kawashima M; Hoshino Y; Sutou T
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2018; 74(4):354-361. PubMed ID: 29681602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-volume histogram analysis of composite EQD2 dose distributions using the central shielding technique in cervical cancer radiotherapy.
    Tamaki T; Noda SE; Ohno T; Kumazaki Y; Kato S; Nakano T
    Brachytherapy; 2016; 15(5):598-606. PubMed ID: 27475482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SU-E-T-606: Optimal Emission Angle Selection in Rotating Shield Brachytherapy.
    Liu Y; Flynn R; Yang W; Kim Y; Wu X
    Med Phys; 2012 Jun; 39(6Part19):3845. PubMed ID: 28517084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High resolution (3 Tesla) MRI-guided conformal brachytherapy for cervical cancer: consequences of different high-risk CTV sizes.
    Anderson JW; Xia J; Flynn RT; Modrick JM; Bhatia SK; Jacobson GM; Kim Y
    J Contemp Brachytherapy; 2013 Jun; 5(2):101-9. PubMed ID: 23878555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implications for dosimetric changes when introducing MR-guided brachytherapy for small volume cervix cancer: a comparison of CT and MR-based treatments in a single centre.
    Dempsey C; Govindarajulu G; Sridharan S; Capp A; O'Brien P
    Australas Phys Eng Sci Med; 2014 Dec; 37(4):705-12. PubMed ID: 25344886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rectal separation using hydroxypropyl methylcellulose in intracavitary brachytherapy of cervical cancer: an innovative approach.
    Basu S; Manir KS; Basu A; Ghosh K
    J Contemp Brachytherapy; 2016 Oct; 8(5):399-403. PubMed ID: 27895681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.